研究疾病:
|
行气除满,开胸除痹。用于痰浊阻络之冠心病,稳定型心绞痛。
|
研究疾病代码:
|
|
Target disease:
|
Exercising qi to eliminate fullness, open chest to eliminate paralysis. Used for coronary heart disease with turbid phlegm blocking the collaterals, stable angina pectoris.
|
Target disease code:
|
研究类型:
Study type:
|
干预性研究
Interventional study
|
研究设计:
Study design:
|
随机平行对照
randomized controlled trial(parallel group design)
|
研究所处阶段:
Study phase:
|
IV期临床试验
Phase IV clinical trial
|
研究目的:
|
主要目的:
1.评价瓜蒌皮注射液治疗冠心病心绞痛的有效性;
2.评价瓜蒌皮注射液治疗冠心病心绞痛的安全性。
|
Objectives of Study:
|
Main purpose:
1.To evaluate the effectiveness of Gualoupi injection in the treatment of coronary heart disease and angina pectoris;
2.To evaluate the safety of Gualoupi injection in the treatment of coronary heart disease and angina pectoris.
|
药物成份或治疗方案详述:
|
|
Description for medicine or protocol of treatment in detail:
|
|
纳入标准:
|
1.年龄18-80岁;
2.育龄期女性必须妊娠试验阴性且不在哺乳期,在研究过程中必须接受为研究者认可的方法避孕;
3.有冠状动脉疾病的证据,包括明确的心梗史(入选前至少3个月),或者经无创性或有创性血管造影证实有显著的冠状动脉疾病;
4.有支持慢性心绞痛诊断的症状和/或曾有对运动有异常反应(出现心绞痛和/或心动图变化)的历史 ;
5.轻中度心绞痛患者(CCS II或III 级);
6.以往使用的慢性硝酸酯类药物(如长效的硝酸甘油)、倍他受体阻滞剂、钙通道阻滞剂、华法林或其他口服抗凝药物用量能逐步减少或能停药者;
7.患者必须理解、愿意、能够和依从本研究方案,并能理解日记卡相关填写内容;
8.患者必须自愿签署知情同意书。
|
Inclusion criteria
|
1. Aged 18 to 80 years;
2. Women of childbearing age must have a negative pregnancy test and are not breastfeeding, and must accept contraceptive methods approved by the researcher during the study;
3. Evidence of coronary artery disease, including a clear history of myocardial infarction (at least 3 months before enrollment), or significant coronary artery disease confirmed by non-invasive or invasive angiography;
4. Have symptoms that support the diagnosis of chronic angina pectoris and/or have a history of abnormal reactions to exercise (angina pectoris and/or cardiogram changes);
5. Patients with mild to moderate angina pectoris (CCS II or III);
6. The amount of chronic nitrate drugs used in the past (such as long-acting nitroglycerin), beta receptor blockers, calcium channel blockers, warfarin or other oral anticoagulant drugs can be gradually reduced or stopped By;
7. The patient must understand, be willing, able and comply with this research plan, and be able to understand the relevant contents of the diary card;
8. The patient must voluntarily sign an informed consent form.
|
排除标准:
|
1.任一导联ST段运动前下降1mm以上,左束支阻滞,使用地高辛,左心室肥厚以及WPW综合征和其他能干扰运动平板心电图图形的患者;
2.临床意义的心律失常,I度以上的房室传导阻滞;
3.合并有临床意义的其它疾病,包括严重肝肾功能不全、肺动脉高压、慢阻肺、脑出血史或癫痫发作需服药;
4.充血性心衰史(心功能一级以下不含一级)、严重心瓣膜病、重度高血压、重度贫血,怀疑或已知有动脉夹层、急性心肌炎或心包炎、血栓静脉炎、肺栓塞或3个月内有心梗史;
5.出血素质,或在使用华法林;
6.起搏器植入者;
7.不能停用正在服用的慢性硝酸酯(如长效硝酸甘油)治疗而只使用短效硝酸甘油或一种β阻滞剂或钙通道阻滞剂;
8.筛选前90天内参加其他临床试验或服用其它研究性药物;
9.研究者认为不适合参加本研究的其他情况。
|
Exclusion criteria:
|
1. Patients with ST-segment drop by more than 1mm before exercise in any lead, left bundle branch block, use of digoxin, left ventricular hypertrophy, WPW syndrome, and other patients who can interfere with the exercise plate electrocardiogram;
2. Arrhythmia of clinical significance, atrioventricular block above 1 degree;
3. Combined with other diseases of clinical significance, including severe liver and kidney insufficiency, pulmonary hypertension, chronic obstructive pulmonary disease, history of cerebral hemorrhage or epileptic seizures, medication is required;
4. History of congestive heart failure (heart function below grade 1 does not include grade 1), severe valvular disease, severe hypertension, severe anemia, suspected or known arterial dissection, acute myocarditis or pericarditis, thrombophlebitis, lung Embolism or history of myocardial infarction within 3 months;
5. Bleeding diathesis, or using warfarin;
6. Pacemaker implanters;
7. Can not stop taking chronic nitrate ester (such as long-acting nitroglycerin) treatment and only use short-acting nitroglycerin or a beta blocker or calcium channel blocker;
8. Participate in other clinical trials or take other research drugs within 90 days before screening;
9. Other situations that the researcher thinks are not suitable for participating in this research.
|
研究实施时间:
Study execute time:
|
从From
2020-04-01
至To
2022-10-31
|
征募观察对象时间:
Recruiting time:
|
从From
2021-05-12
至To
1990-01-01
|